Stay updated on HD IL-2 + Anti-PD-1 for Anti-PD-1 Resistant MM & RCC Clinical Trial
Sign up to get notified when there's something new on the HD IL-2 + Anti-PD-1 for Anti-PD-1 Resistant MM & RCC Clinical Trial page.

Latest updates to the HD IL-2 + Anti-PD-1 for Anti-PD-1 Resistant MM & RCC Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This appears to be a minor site-wide version update that does not affect the study information.SummaryDifference0.1%

- Check18 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1; this is a metadata change and does not affect the study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedMinor UI and metadata updates are present, including the new 'Show glossary' option and revised QC-related labels and revision version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check39 days agoChange DetectedRevision: v3.3.4 is displayed on the page. This update appears to be a system version change and does not alter study details, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check67 days agoChange DetectedAdded a Locations section with California as the site and removed the California Locations entry. Updated revision metadata to v3.3.3 and removed the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check89 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.3.1 on the page, representing a small version update with no impact on the study information or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to HD IL-2 + Anti-PD-1 for Anti-PD-1 Resistant MM & RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HD IL-2 + Anti-PD-1 for Anti-PD-1 Resistant MM & RCC Clinical Trial page.